Member Info for nomlungu

What percentage discount are you expecting on a distressed placing?

Good evening C7,

Do you appreciate the role of degraded proteins resulting from immature dendritic cells and the problems caused by the protein fragments appearing on cell surfaces.

https://www.sciencemag.org/news/2018/12/google-s-deepmind-aces-protein-folding

https://deepmind.com/blog/alphafold/

This may make some laugh (Happy Brexit Day, as shared by kenny100):

https://www.youtube.com/watch?v=FhdVfbj9_o8

Feking Lazycow!

In a market sensing a global downturn who cares what the average published broker consensus is?

The market knows that there is an Elephant in the room that is stomping its foot - MTRO has to raise funds and it is unlikely to be at a premium to the prevailing share price. The share price is likely to keep dropping until the BOD advise the Market via an RNS what their plans are.

The fight amongst Chinese food delivery companies has gone epic:

https://www.bloomberg.com/features/2019-meituan-china-delivery-empire/?srnd=premium-europe

Jace86,

I agree but I do not expect them to walk - I doubt that PIs will be able to call an EGM quickly enough to prevent wipe-out if the resolutions fail.

I hate seeing shareholders being fleeced by 'mens in suits'.

No - but why would some vote in such a way that administration becomes inevitable \ justifiable by the BOD?

Are they going to buy the cash shell from the Administrators leaving the shareholders with fek-all?

Makes you wonder the motivation of the posters who relentlessly posted that some of the resolutions should be voted down. Have they made a mistake or were there ulterior motives in play?

Freddy,

The trade was late reported. The way it is shown here shows the bid and ask when the trade was reported, not the bid and ask when the trade happened. It is why I posted the link that shows the trades on the 26th as it shows the prices that shares were trading at then.

Surely you understand that such a large 'buy' would be at premium to the prevailing price, not a discount hence my comment that it was a sell.

http://pumpedordumped.com/data/show_trades.php?search=VAL&date=26-03-2019

Freddy, I posted this yesterday:

If you look at the trade time you will see it was at 26-Mar-19 08:31:27 and priced at 0.6148p. If it was a buy I would expect such a large order to be at a premium to the market price. But buys were going through at 0.64p at the time.

As FunkyGibbon says 'Who knows ?'. Nonetheless I expect it was a sale.

http://pumpedordumped.com/data/show_trades.php?search=VAL&date=26-03-2019

Nice one Kenny - pity Eaton would not accept me because I did not have blue blood.

Surely that is called gambling not investing?

Watch the contagion - the French banks are over exposed to Italian debt.

The RNS includes the statement:

'The Company also expects that the VAT accounting policies they intend to adopt may have an impact on profitability going forward.'

Are the margins are so low that once they include VAT they become loss-making? Seems to be an own goal even before you consider the other factors.

A Bloomberg article about Indian health care costs in the face of Modicare:

https://www.bloomberg.com/news/features/2019-03-26/the-world-s-cheapest-hospital-has-to-get-even-cheaper

A bit off topic but Scancell does not appear to have patent protection in India or, possibly more importantly, Egypt [which is a leader in generic medicines] which refuses to patent many classes of drugs. An example below is about Egypt's approach to Hepatitis-C:

https://www.theatlantic.com/health/archive/2018/05/why-egypt-is-at-the-forefront-of-hepatitis-c-treatment/561305/

Bloomberg report about Angela Merkel's panel of experts:

https://www.bloomberg.com/news/articles/2019-03-27/millions-of-electric-cars-needed-in-germany-s-war-on-pollution?srnd=premium-europe

https://www.bloomberg.com/news/articles/2019-03-27/may-s-deal-gains-support-ahead-of-votes-on-plan-b-brexit-update

She is offering to go as soon as Friday if her deal is voted through?

If you look at the trade time you will see it was at 26-Mar-19 08:31:27 and priced at 0.6148p. If it was a buy I would expect such a large order to be at a premium to the market price. But buys were going through at 0.64p at the time.

As FunkyGibbon says 'Who knows ?'. Nonetheless I expect it was a sale.

http://pumpedordumped.com/data/show_trades.php?search=VAL&date=26-03-2019

2 separate phase 3 clinical trials? Seriously?